109 related articles for article (PubMed ID: 25752890)
21. Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer.
Zhao T; Zhang Y; Ma X; Wei L; Hou Y; Sun R; Jiang J
Cancer Cell Int; 2021 May; 21(1):269. PubMed ID: 34016103
[TBL] [Abstract][Full Text] [Related]
22. LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma.
Tao M; Luo J; Gu T; Yu X; Song Z; Jun Y; Gu H; Han K; Huang X; Yu W; Sun S; Zhang Z; Liu L; Chen X; Zhang L; Luo C; Wang Q
Cell Death Dis; 2021 Sep; 12(9):845. PubMed ID: 34518524
[TBL] [Abstract][Full Text] [Related]
23. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways.
Huang Y; Wang Y; Wang Y; Wang N; Duan Q; Wang S; Liu M; Bilal MA; Zheng Y
J Invest Dermatol; 2022 Feb; 142(2):303-313.e9. PubMed ID: 34358528
[TBL] [Abstract][Full Text] [Related]
24. Identification of
Wang K; Wu Z; Si Y; Tang W; Xu X; Cheng Y; Lin J
Oncol Lett; 2021 Feb; 21(2):105. PubMed ID: 33376538
[TBL] [Abstract][Full Text] [Related]
25. Membrane Lipid Remodeling Takes Center Stage in Growth Factor Receptor-Driven Cancer Development.
Swinnen JV; Dehairs J; Talebi A
Cell Metab; 2019 Sep; 30(3):407-408. PubMed ID: 31484051
[TBL] [Abstract][Full Text] [Related]
26. LPCAT1 levels in the placenta, the maternal plasma and the fetal plasma do not predict fetal lung responses to glucocorticoids in a sheep model of pregnancy.
Takahashi T; Fee EL; Takahashi Y; Usuda H; Carter SWD; Ikeda H; Saito M; Kumagai Y; Bridges JP; Jobe AH; Choolani MA; Kemp MW
Placenta; 2023 Jul; 138():1-9. PubMed ID: 37146534
[TBL] [Abstract][Full Text] [Related]
27. Lysophosphatidylcholine acyltransferase 1 controls mitochondrial reactive oxygen species generation and survival of retinal photoreceptor cells.
Nagata K; Hishikawa D; Sagara H; Saito M; Watanabe S; Shimizu T; Shindou H
J Biol Chem; 2022 Jun; 298(6):101958. PubMed ID: 35452679
[TBL] [Abstract][Full Text] [Related]
28. A miR-205-LPCAT1 axis contributes to proliferation and progression in multiple cancers.
Liu F; Wu Y; Liu J; Ni RJ; Yang AG; Bian K; Zhang R
Biochem Biophys Res Commun; 2020 Jun; 527(2):474-480. PubMed ID: 32334831
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidylcholine acyltransferase 1 protects against cytotoxicity induced by polyunsaturated fatty acids.
Akagi S; Kono N; Ariyama H; Shindou H; Shimizu T; Arai H
FASEB J; 2016 May; 30(5):2027-39. PubMed ID: 26887439
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal copy number amplification-driven Linc01711 contributes to gastric cancer progression through histone modification-mediated reprogramming of cholesterol metabolism.
Yue B; Chen J; Bao T; Zhang Y; Yang L; Zhang Z; Wang Z; Zhu C
Gastric Cancer; 2024 Mar; 27(2):308-323. PubMed ID: 38270815
[TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidylcholine acyltransferase level predicts the severity and prognosis of patients with community-acquired pneumonia: a prospective multicenter study.
Chen L; Xue J; Zhao L; He Y; Fu S; Ma X; Yu W; Tang Y; Wang Y; Gao Z
Front Immunol; 2023; 14():1295353. PubMed ID: 38259459
[TBL] [Abstract][Full Text] [Related]
32. PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer.
Chauhan SS; Casillas AL; Vizzerra AD; Liou H; Clements AN; Flores CE; Prevost CT; Kashatus DF; Snider AJ; Snider JM; Warfel NA
Oncogene; 2024 Feb; 43(6):406-419. PubMed ID: 38097734
[TBL] [Abstract][Full Text] [Related]
33. Deep dissection of stemness-related hierarchies in hepatocellular carcinoma.
Liang R; Hong W; Zhang Y; Ma D; Li J; Shi Y; Luo Q; Du S; Song G
J Transl Med; 2023 Sep; 21(1):631. PubMed ID: 37717019
[TBL] [Abstract][Full Text] [Related]
34. Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas-A Preliminary Study.
Skubisz K; Dąbkowski K; Samborowska E; Starzyńska T; Deskur A; Ambrozkiewicz F; Karczmarski J; Radkiewicz M; Kusnierz K; Kos-Kudła B; Sulikowski T; Cybula P; Paziewska A
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370852
[TBL] [Abstract][Full Text] [Related]
35. Association between abnormal lipid metabolism and tumor.
Li C; Wang F; Cui L; Li S; Zhao J; Liao L
Front Endocrinol (Lausanne); 2023; 14():1134154. PubMed ID: 37305043
[TBL] [Abstract][Full Text] [Related]
36. LPCAT1 enhances the invasion and migration in gastric cancer: Based on computational biology methods and in vitro experiments.
Chen ZX; Liang L; Huang HQ; Li JD; He RQ; Huang ZG; Song R; Chen G; Li JJ; Cai ZW; Huang JA
Cancer Med; 2023 Jun; 12(12):13438-13454. PubMed ID: 37184260
[TBL] [Abstract][Full Text] [Related]
37. TRAF3: A novel regulator of mitochondrial physiology and metabolic pathways in B lymphocytes.
Jung J; Gokhale S; Xie P
Front Oncol; 2023; 13():1081253. PubMed ID: 36776285
[TBL] [Abstract][Full Text] [Related]
38. Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics.
Pal S; Sharma A; Mathew SP; Jaganathan BG
Front Immunol; 2022; 13():955476. PubMed ID: 36618350
[TBL] [Abstract][Full Text] [Related]
39. Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression.
He MJ; Pu W; Wang X; Zhong X; Zhao D; Zeng Z; Cai W; Liu J; Huang J; Tang D; Dai Y
Cancer Cell Int; 2022 Nov; 22(1):366. PubMed ID: 36419080
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
